Transasia Bio-Medicals Ltd.

Transasia Bio-Medicals Ltd. Transasia is a leader in the In-vitro Diagnostic segment in India, with world-class products and sol

Welcoming new talent to the Erba Transasia family!We are delighted to welcome Rajesh Kumar, Yogesh Sharma, Ajay Gupta, a...
29/05/2026

Welcoming new talent to the Erba Transasia family!
We are delighted to welcome Rajesh Kumar, Yogesh Sharma, Ajay Gupta, and Judhisthir Kurmi to our Technical Service Division team.
At Erba Transasia, our people are the driving force behind our vision of Creating a Healthier and Happier World through innovative, affordable, and accessible diagnostic solutions.
Wishing our new team members a successful and fulfilling journey ahead as we continue transforming healthcare across India together.

Diagnostics HealthcareInnovation IAmTransasia WeAreErba

Celebrating the spirit of sacrifice, compassion, and togetherness this Eid Ul Adha.May this festive occasion bring peace...
28/05/2026

Celebrating the spirit of sacrifice, compassion, and togetherness this Eid Ul Adha.
May this festive occasion bring peace, prosperity, and happiness to every home, while inspiring us to care, share, and grow stronger as one community.

From all of us at Erba Transasia, we wish you and your loved ones a blessed Eid Mubarak!

IAmTransasia Healthcare Diagnostics Innovation Peace Prosperity

We have made things easier for you to connect with us ✨🤝
12/05/2026

We have made things easier for you to connect with us ✨🤝

19/04/2026

On the occasion of World Liver Day, Prof. Dr. K. Narayanasamy, Vice Chancellor, The Tamil Nadu Dr. M. G. R. Medical University, highlights that early, data-driven diagnostics are pivotal in improving liver disease outcomes. Subclinical changes in liver enzymes often preceding symptoms. serve as critical early indicators, while collective interpretation of key LFT parameters such as ALT, AST, ALP, bilirubin, and albumin enables a more accurate assessment of hepatic function and disease progression.

Advancements in biomarkers and testing methodologies are further enhancing early detection, particularly for subtle hepatocellular injury and fibrosis. For high-risk groups, including individuals with diabetes or chronic alcohol use, structured and frequent screening is essential for timely diagnosis.

He also underscores the vital role of laboratories in ensuring rapid, accurate, and standardized results. Automation, streamlined workflows, and robust quality control significantly improve turnaround time and diagnostic confidence, supporting timely clinical decisions.

At Erba Transasia, we’re committed to advancing diagnostic excellence by providing laboratories with reliable, innovative solutions that support early detection and informed clinical care.

TimelyDetection

India’s diversity shines through its vibrant festivals, each marking new beginnings, gratitude, and prosperity.From Vish...
15/04/2026

India’s diversity shines through its vibrant festivals, each marking new beginnings, gratitude, and prosperity.
From Vishu, Pohela Boishakh, Bohag Bihu to Pana Sankranti, this season celebrates renewal, resilience, and hope across the nation.
As we embrace these traditions, we are reminded that progress, whether in healthcare, science, or society, is rooted in strong cultural foundations and shared aspirations.
Wishing everyone a joyful, prosperous, and healthy festive season!

Prosperity IAmTransasia WeAreErba

*Growth first. One shared commitment*As part of the Erba Transasia Leadership Development Initiative, TransLens, 30+ sen...
13/04/2026

*Growth first. One shared commitment*

As part of the Erba Transasia Leadership Development Initiative, TransLens, 30+ senior leaders are investing in a focused six-month experential learning journey to build timeless leadership capabilities, under the mentorship of our Global CEO, Nishant Saxena.

With three of the six sessions completed, the journey is already demonstrating strong impact. The sessions have been rated 4.9 / 5 with 100% of participants finding them highly to extremely resourceful, reflecting both relevance and depth.

Rooted in experiential learning and a blended format, the initiative combines real-world application, reflection, and dialogue. A structured emphasis on teach-back has led to 30 sessions delivered by participants, extending the learning to 80+ team members and reinforcing a culture of shared growth.

The focus on self-awareness, empathy, and evolving from individual contributor to leader is enabling participants to align more closely with current and future role expectation.

Welcome New Year Offer: Save big on our best-selling analyzers with up to 45% Off. Limited time — Book now or contact us...
07/01/2026

Welcome New Year Offer: Save big on our best-selling analyzers with up to 45% Off.

Limited time — Book now or contact us to get the quote.
Fill this form: https://survey.transasia.co.in/zs/gkDcPt

Offer ending soon. Don’t miss out.

Upgrade your lab efficiency this January!Get an Erba Pipette FREE* on purchase of Erba Liquixx Reagents worth ₹15,000.  ...
03/01/2026

Upgrade your lab efficiency this January!
Get an Erba Pipette FREE* on purchase of Erba Liquixx Reagents worth ₹15,000.

We’ve moved! 🎉Follow our new official Transasia Bio-Medicals Ltd. page to stay updated on offers, product launches, and ...
09/12/2025

We’ve moved! 🎉

Follow our new official Transasia Bio-Medicals Ltd. page to stay updated on offers, product launches, and everything exciting we’re working on.

Join us here: https://www.facebook.com/TransasiaBioMedicalsIN/

06/12/2025

Address

Transasia House, 8 Chandivali Road, Andheri East
Mumbai
400072

Opening Hours

Monday 8:45am - 7:30pm
Tuesday 8:45am - 7:30pm
Wednesday 8:45am - 7:30pm
Thursday 8:45am - 7:30pm
Friday 8:45am - 7:30pm
Saturday 8:45am - 7:30pm

Telephone

+91 22 4030 9000

Alerts

Be the first to know and let us send you an email when Transasia Bio-Medicals Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Transasia Bio-Medicals Ltd.:

Share